bexarotene has been researched along with cycloheximide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, JB; Black, CC; Dmitrovsky, E; Dragnev, K; Feng, Q; Galimberti, F; Guo, Y; Hassel, BA; Liu, X; Memoli, V; Sekula, D; Sempere, LF; Shah, SJ | 1 |
1 other study(ies) available for bexarotene and cycloheximide
Article | Year |
---|---|
UBE1L causes lung cancer growth suppression by targeting cyclin D1.
Topics: Anticarcinogenic Agents; Bexarotene; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cycloheximide; Cytokines; Humans; Ki-67 Antigen; Lung Neoplasms; Models, Biological; Plasmids; Retinoid X Receptors; Tetrahydronaphthalenes; Ubiquitin-Activating Enzymes; Ubiquitins | 2008 |